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Abstract
Background: BC RNAs and the fragile X mental retardation protein (FMRP) are translational repressors that have been
implicated in the control of local protein synthesis at the synapse. Work with BC1 and Fmr1 animal models has revealed that
phenotypical consequences resulting from the absence of either BC1 RNA or FMRP are remarkably similar. To establish
functional interactions between BC1 RNA and FMRP is important for our understanding of how local protein synthesis
regulates neuronal excitability.
Methodology/Principal Findings: We generated BC12/2 Fmr12/2 double knockout (dKO) mice. We examined such
animals, lacking both BC1 RNA and FMRP, in comparison with single knockout (sKO) animals lacking either one repressor.
Analysis of neural phenotypical output revealed that at least three attributes of brain functionality are subject to control by
both BC1 RNA and FMRP: neuronal network excitability, epileptogenesis, and place learning. The severity of CA3 pyramidal
cell hyperexcitability was significantly higher in BC12/2 Fmr12/2 dKO preparations than in the respective sKO
preparations, as was seizure susceptibility of BC12/2 Fmr12/2 dKO animals in response to auditory stimulation. In place
learning, BC12/2 Fmr12/2 dKO animals were severely impaired, in contrast to BC12/2 or Fmr12/2 sKO animals which
exhibited only mild deficits.
Conclusions/Significance: Our data indicate that BC1 RNA and FMRP operate in sequential-independent fashion. They
suggest that the molecular interplay between two translational repressors directly impacts brain functionality.
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Introduction
A key determinant in the experience-dependent interpretation
of genetic information is provided by local translational control of
gene expression at neuronal synapses. The regulated translation of
select mRNAs at synaptic sites is now recognized as a core
mechanism in the long-term modulation of neuronal interactions
[1–4]. Several types of translational regulators have been identified
in neurons, including the fragile X mental retardation protein
(FMRP) [5–7] and regulatory BC RNAs [8,9].
Functional absence of FMRP gives rise to the fragile X
syndrome (FXS) [10], a common inherited form of mental
retardation that is characterized by cognitive impairments,
behavioral abnormalities and, in subpopulations of FXS patients,
by epileptic and/or autistic phenotypes [11]. FMRP is an RNA-
binding protein that interacts with a subset of neuronal RNAs
[12–17]. The protein operates as a translational repressor [17–19],
most likely via association with neuronal polyribosomes [20–23]
[but see 19,24].
Regulatory BC RNAs repress translation at the initiation level
[25–28]. Absence of dendritic BC1 RNA results in neuronal
hyperexcitability and epileptogenesis [29]. The apparent pheno-
typical commonalities between impaired BC1 RNA and FMRP
translational control [see 29,30,31] prompt the question whether
the two systems are functionally intersecting. Is the overlapping
phenotypical output the result of pathway modulations that are
implemented sequentially (and thus likely in independent fashion)
or concomitantly (and thus possibly in mutually interdependent
fashion)? Answers to these questions will be directly relevant to our
understanding of the molecular basis of FXS and associated
disorders. Therefore, in the present work, we undertook a
functional dissection of FMRP and BC1 RNA translational
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e15509Figure 1. Concurrent absence of BC1 RNA and FMRP gives rise to exacerbated synaptic hyperexcitability of CA3 pyramidal cells.
(A) Prolonged epileptiform discharges induced by bicuculline (Bic) in hippocampal slices occurred earlier (20 min) in BC12/2 Fmr12/2 slice
preparations (right column) than in BC12/2 (left column) or Fmr12/2 (middle column) preparations. (B) Summary frequency histograms from each
BC1 RNA and FMRP
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BC12/2 Fmr12/2 animal model systems.
Results
Exacerbated Hyperexcitability of the CA3 Neuronal
Network
We examined synaptic excitability and epileptogenic suscepti-
bility using electrophysiological approaches. Intracellular record-
ings were performed in CA3 glutamatergic principal neurons of
hippocampal slice preparations from BC12/2, Fmr12/2,
BC12/2 Fmr12/2, and WT animals. Epileptiform discharges
were elicited by application of bicuculline, a GABAA receptor
antagonist [31]. This disinhibition causes short (,1.5 s) synchro-
nized discharges that are stable over the recording period in WT
animals; they result in elevated synaptic release of glutamate from
principal neurons [31].
In all three mutant preparations, but not in WT preparations,
such short discharges over time transformed into recurrent
prolonged synchronized discharges (duration.1.5 s) that are
similar to ictal events in epilepsy [Fig. 1; see also 29,31]. This
transition of discharge duration from a unimodal phase (short
bursts only) to a bimodal phase (long bursts in addition to short
bursts) was significantly accelerated in hippocampal slices
prepared from BC12/2 Fmr12/2 dKO animals. Prolonged
discharges appeared after only 20 min in dKO preparations
(Fig. 1A and 1B, right columns), whereas they did not begin to
occur until after 30–40 min in sKO preparations (Fig. 1, left and
center columns). In addition, at time points 20 min or more after
bicuculline application, epileptiform discharges in BC12/2
Fmr12/2 dKO slices were significantly longer (Fig. 1B, 20 and
40 min) and occurred more frequently (Fig. 1B, right column) than
in either type of sKO slices. Thus, prolonged discharges (i)
appeared earlier, (ii) were of longer average duration, and (iii)
occurred at a higher relative frequency in BC12/2 Fmr12/2
dKO preparations than in either BC12/2 or Fmr12/2 sKO
preparations. The data indicate that the concurrent absence of
BC1 RNA and FMRP precipitates a significantly higher level of
neuronal hyperexcitability than the absence of one repressor
alone.
Heightened Epileptogenic Susceptibility
To investigate epileptogenic vulnerability in vivo, WT animals
and BC12/2, Fmr12/2, and BC12/2 Fmr12/2 mutant
animals were subjected to auditory stimulation. When exposed to
a 120 dB sound, animals of the three mutant mouse strains, but
not WT animals, typically initiated excessive motor activity in the
form of wild, uncontrolled running and jumping, as has previously
been described for BC12/2 and Fmr12/2 sKO animals
[29,32,33]. Such wild running was followed, within less than 2
minutes, by generalized tonic-clonic seizures (Fig. 2; Movie S1).
The percentage of animals undergoing convulsive seizures was
high for all three mutant strains (.75%; Fig. 2A). However, while
most sKO animals recovered from such seizures within less than 2
minutes, a remarkably high percentage of BC12/2 Fmr12/2
dKO animals died while undergoing seizures (.86% lethality
within ,90 s after onset of alarm) (Fig. 2B). Thus, BC1-/2
Fmr12/2 dKO animals are acutely susceptible to audiogenic
epileptogenesis, and epileptic lethality is significantly increased in
comparison to BC12/2 or Fmr12/2 sKO animals (Fig. 2).
These results are corroborated by data indicating that initial
epileptogenic responses (uncontrolled running) were triggered faster
in BC12/2 Fmr12/2 dKO animals than in either BC12/2
animals or Fmr12/2 animals. The percentages of animals in
uncontrolled running at 10 s, 15 s, and 20 s after start of the alarm
were significantly higher in the BC12/2 Fmr12/2 group than in
either the BC12/2 or the Fmr12/2 group (Fig. S1).
The combined results indicate that concomitant absence of BC1
RNA and FMRP results in severely heightened susceptibility to
hyperexcitability and epileptogenesis, in comparison with animal
models that lack only one type of translational repressor.
Impaired Place Learning
We used an active place avoidance paradigm [34] to assess
place learning in sKO and dKO animals. As shown in Fig. 3A,
WT animals quickly learned to avoid entering a rotating shock
zone, reaching their performance asymptote by the third trial on
the first day of training. Learning in BC12/2 and Fmr12/2
sKO animals was also robust but retarded in comparison to the
WT animals. However, in clear contrast to learning in sKO
animals, active place avoidance in dKO animals did not improve
at all, even over 3 days of training (Fig. 3).
Thus, while place learning was preserved although retarded in
both groups of sKO animals, a severe learning deficit was
apparent in dKO animals.
Discussion
We used three phenotypical readouts -— neuronal network
excitability, epileptogenesis, and place learning -— to evaluate the
relative contributions of two translational repressors, BC1 RNA
and FMRP, to brain function. We report that in all three cases,
phenotypical deficiencies were significantly exacerbated in
BC12/2 Fmr12/2 dKO animals, relative to BC12/2 or
Fmr12/2 sKO animals. As will be discussed in the following,
these results have critical implications concerning the mode of
functional interactions between the two repressors, BC1 RNA and
FMRP.
Neuronal excitability was examined in hippocampal CA3
pyramidal cells. Previous work has shown that in BC12/2 and
Fmr12/2 preparations, synaptic glutamate release elicits ictal-
like prolonged epileptiform discharges [29,31]. We now observe
that the severity of such hyperexcitability is significantly height-
ened in BC12/2 Fmr12/2 dKO preparations. This phenotyp-
of the three groups of preparations (n, number of slices; one slice per animal) with second-order Gaussian function fits. The appearance of a second
distinct peak of burst duration distribution indicates burst prolongation. Bicuculline-elicited burst prolongation occurred in all the three groups but
was most prominent in BC12/2 Fmr12/2 preparations, evidenced as follows. (i) Between 10 and 20 min of bicuculline, burst durations significantly
increased in the BC12/2 Fmr12/2 group (10 min: 0.21360.008 s; n=22; 20 min: 1.31660.228 s; n=29; two-way ANOVA followed by Newman-
Keuls post-hoc test: P,0.01), whereas burst durations did not change in the BC12/2 (10 min: 0.21660.005 s; n=24; 20 min: 0.28760.016 s; n=30)
or Fmr12/2 (10 min: 0.23060.013 s; n=13; 20 min: 0.61660.026 s; n=35) groups. (ii) Beginning at 20 min of bicuculline, burst durations were
significantly longer in BC12/2 Fmr12/2 slices than in BC12/2 or in Fmr12/2 slices (P,0.01 in all cases). At 40 min bicuculline, the mean duration
of long bursts was greater in BC12/2 Fmr12/2 (4.41360.279 s; n=13) than in BC12/2 (2.99260.164 s; n=11; P,0.001) or in Fmr12/2 slices
(2.70560.264 s; n=9; P,0.001). (iii) The relative frequency of long bursts (as percentage of total number of bursts) was significantly higher in
BC12/2 Fmr12/2 (Bic 30 min: 67.9%; Bic 40 min: 68.4%) than in BC12/2 (Bic 30 min: 21.9%; x
2 test, P,0.001; Bic 40 min: 29.7%; P,0.01) or in
Fmr12/2 preparations (Bic 30 min: 15.1%; P,0.001; Bic 40 min: 29.0%; P,0.01).
doi:10.1371/journal.pone.0015509.g001
BC1 RNA and FMRP
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mirrored in aggravated epileptogenesis in vivo. Sensitivity to
audiogenic seizures, as previously described for BC12/2 and
Fmr12/2 animals [29,32,33] was also observed in BC12/2
Fmr12/2 dKO animals. However, in contrast to sKO animals in
which lethality from audiogenic seizures is in the range of 20–30%,
Figure 2. Severe epileptogenic susceptibility of BC12/2 Fmr12/2 dKO animals results in high lethality. (A) Lack of BC1 RNA, FMRP, or
both, significantly increased propensity for audiogenic seizures (Generalized Linear Model, followed by post-hoc tests of pairs of groups using exact
logistic regression stratified by litter; P,0.0001 for each group when compared to WT). (B) Rate of lethality resulting from audiogenic seizures was
significantly higher in BC12/2 Fmr12/2 animals than in BC12/2 animals (P,0.0001) or in Fmr12/2 animals (P=0.0007). All mutant animals had a
significantly higher audiogenic lethality rate compared with WT (BC12/2 Fmr12/2,P ,0.0001; BC12/2, P=0.008; Fmr12/2,P ,0.0001). BC12/2
animals did not significantly differ from Fmr12/2 animals in audiogenic lethality (P=0.0719). Error bars represent 95% confidence intervals. WT,
n=30; BC12/2, n=31; BC12/2 Fmr12/2, n=37; Fmr12/2, n=29.
doi:10.1371/journal.pone.0015509.g002
Figure 3. Place learning is mildly impaired in BC12/2 and Fmr12/2 sKO mice but severely impaired in BC12/2 Fmr12/2 dKO
mice. (A) Exploration, measured as the number of entrances into a 60u zone (gray sector on the circle in the schematic), did not differ amongst the
groups on the pre-training trial when the shock was off (F3,26=0.38; P=0.8). When the shock was turned on (red sector), all groups except the dKO
learned to avoid the shock zone. The effects of genotype and trial across place training were significant (genotype: F3,234=141.81; P=10
252;
F8,234=4.96; P=10
25) and the interaction was not (F24,234=0.70; P=0.85). Newman-Keuls post-hoc tests confirmed that the overall number of
entrances significantly differed between all groups (WT,Fmr12/2,BC12/2,dKO). The failure of the dKO to learn persisted across 3 days of
training (3 trials/day) and this was confirmed by 1-way ANOVA on the factor trial (F8,45=1.02; P=0.43). (B) Summary of behavior on the pre-training
and active avoidance trials illustrates the significant group differences during place learning. Error bars indicate S.E.M., *P,0.05, ***P,0.001. BC12/2,
n=6; Fmr12/2, n=6; dKO, n=6; WT, n=12.
doi:10.1371/journal.pone.0015509.g003
BC1 RNA and FMRP
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found approaching 90%. It appears that absence of the
translational repressors BC1 RNA and FMRP contribute in
modular fashion to phenotypical impairments.
In the active place avoidance paradigm, BC12/2 and
Fmr12/2 sKO animals exhibited only mild place learning
deficits, results that are in agreement with previous observations
that such animals showed no or only mild learning impairments in
the Morris water maze and other maze tasks [35–37]. In contrast,
BC12/2 Fmr12/2 dKO animals were severely impaired in
their place learning ability. We note that the active place
avoidance task goes beyond testing spatial and navigation ability
[38] because optimal performance requires the mouse to segregate
the useful spatial information from the stationary spatial frame
from the irrelevant spatial information from the rotating spatial
frame. Indeed, the ability to segregate spatial information has been
dissociated from the ability to form spatial associations [39]. These
properties may make the active place avoidance task exquisitely
sensitive to even mild hippocampal dysfunction [40,41], certainly
more than the water maze [39,42], and possibly more than other
place learning tasks. In summary, data obtained in three readouts
of brain function indicate that concurrent lack of both BC1 RNA
and FMRP significantly compounds the phenotypical consequenc-
es that are observed in the absence of only one repressor.
The results presented here indicate that the repressors BC1
RNA and FMRP operate sequentially in the translation pathway
(Fig. 4). In this scenario, the repressors act in series and
independently of each other. Therefore, lack of one repressor will
leave the respective other repressor unaffected and functional, and
phenotypical output will be less severely impacted than in the case
of concurrent absence of both repressors. This model is also
compatible with recent results showing that defects of striatal
mGluR5-endocannabinoid signaling were significantly exacerbat-
ed in BC12/2 Fmr12/2 dKO preparations [43] [but see 44].
Conversely, our results are not compatible with a model in which
BC1 RNA and FMRP operate in interdependent fashion [24] as
in this case, lack of both repressors should precipitate the same
phenotypical consequences as lack of either one repressor. We
conclude that the mode of action of BC1 RNA and FMRP is
sequential-independent.
Figure 4. BC1 RNA and FMRP act as repressors on activity-stimulated translation. In this model, a balance of power is maintained in the
postsynaptic translation pathway by the functional interplay between two opposing forces: (i) the stimulatory consequences of receptor activation,
and (ii) translational repression by BC1 RNA and FMRP. It is suggested that BC1 RNA and FMRP, operating in series in the same translational pathway,
target overlapping but non-identical sets of mRNAs. We posit that multiple repressors are needed at the synapse to ensure adequate stimulation-
repression homeostasis and to allow for differential derepression options.
doi:10.1371/journal.pone.0015509.g004
BC1 RNA and FMRP
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neuron to respond to external stimuli in an input-specific,
experience-dependent manner [2,45]. However, such gains in
neuronal plastic responsiveness come at a price: a protein synthetic
machinery that, unless properly controlled, may engage in
premature or inappropriate translation of locally available
mRNAs, resulting in neuronal hyperexcitability. We suggest that
effective local translational repression is vital for a neuron to
ensure that proteins are only synthesized when and where needed.
BC RNAs and FMRP represent two types of neuronal
translational repressors. Previous work has established a balance
of power between receptor activation on one hand and
translational repression by BC1 RNA and FMRP on the other
[7,29,46]. Translational repressors thus operate as ‘‘brakes’’ that
counteract receptor-mediated translational stimulation (Fig. 4),
establishing a stimulation-repression balance that controls trans-
lational output in accordance with the physiological status of the
synapse. Such brakes have been in place early during phylogenetic
brain development as an FMRP ortholog exists in Drosophila
[47]. In contrast, dendritic BC RNAs are mammalian-specific,
with BC1 RNA restricted to rodents (Rodentia), BC200 RNA
restricted to simian primates (Anthropoidea) [48,49]. It is therefore
likely that these RNAs were independently recruited into their
current repression function at a later time in mammalian evolution
during which increasing brain complexity required more stringent
translational control mechanisms. Multiple, mutually independent
translational control mechanisms in neurons may also allow for
more discrete regulation by upstream signals. The evolution of
neuronal RNA-coding genes thus appears to be linked to
increasing nervous system complexity in eukaryotes [50,51].
Materials and Methods
Animals
Work with vertebrate animals was in accordance with the
Public Health Service Policy on Humane Care and Use of
Laboratory Animals and was approved by the State University
of New York Brooklyn Institutional Animal Care and Use
Committee (Institutional Assurance Number A3260-01, Protocol
Number 10-074-09).
BC12/2 mice (lines 13 and 15) were established from
independent mutant ES cell lines [52] and used as described
[53]. Both lines have a mixed C57BL6/sv129 background. Lines
13 and 15 were used (with equivalent results) for experiments
shown in Figs. 1 and 2, line 15 was used for experiments shown in
Fig. 3. Fmr12/2 mice carrying the Fmr1
tm1Cgr allele were
obtained from Jackson Laboratories (Bar Harbor, ME), and have a
mixed C57BL6/FVB background. BC12/2 mice were crossed
with Fmr12/2 mice to generate BC12/2 Fmr12/2 mice
which have a mixed C57BL6/FVB/sv129 background. We used
animals at 18–21 days of age except for place learning tasks in
which animals at 2–4 months were used.
Hippocampal Slice Preparations and Electrophysiological
Recordings
Transverse hippocampal slices (400 mm) were prepared as
described [54]. Slices were allowed to recover from the isolation
procedure for at least 1.5 h. Intracellular recordings were carried
out in CA3 pyramidal cells using an Axoclamp 2A amplifier
(Molecular Devices, Palo Alto, CA) as described [29].
Auditory Stimulation
Epileptogenic susceptibility to auditory stimuli was tested as
described [29]. Animals were subjected to auditory stimulation for
15 minutes. Video recordings were analyzed by a person who was
not informed of the animals’ genotypes. Recorded parameters
included: time to onset of uncontrolled running, time to onset of
seizure, percentage of animals undergoing seizures, and lethality.
Place Learning
We used an active place avoidance paradigm to examine place
learning [34]. All animals were trained in a task that requires
intact hippocampal function for learning, consolidation and recall
[34] as well as hippocampal LTP maintenance by persistent
activation of PKMf for long-term memory storage [42,55]. The
mice were habituated to a rotating arena during a 10-min pre-
training session. Active avoidance training began on the following
trials by activating a stationary 60u sector as a shock zone.
Data Analysis and Statistical Evaluation were performed as
described [29].
Supporting Information
Figure S1 Initial epileptogenic responses were trig-
gered significantly faster in BC12/2 Fmr12/2 dKO
animals. Percentages of animals in uncontrolled running after
10 s, 15 s, and 20 s were significantly higher in the BC12/2
Fmr12/2 group than in either the BC12/2 or the Fmr12/2
group (Generalized Linear Model, followed by post-hoc tests of
pairs of groups using exact logistic regression stratified by litter,
P,0.0001 for 10 s, 15 s, and 20 s groups). The BC12/2 and the
Fmr12/2 groups did not significantly differ from each other.
Error bars represent 95% confidence intervals. (EPS)
Movie S1
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